Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
Abstract Background In the last 20-30 years, many international studies have found substantial differences in the use of (older) psychotropic medication between European countries. The majority mentioned an important role for attitudes and beliefs towards psychotropic medication. So far, no studies...
Saved in:
Main Authors: | J. M. Hoebert (Author), A. K. Mantel-Teeuwisse (Author), H. G. M. Leufkens (Author), L. van Dijk (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linking market authorizations of medicines with disease burden in South Africa
by: K. Narsai, et al.
Published: (2021) -
An Evaluation of the Diversity of the Film Market for Cinema and Video Recordings in France and in Europe
by: Florence Lévy-Hartmann -
Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
by: Jarosławski Szymon, et al.
Published: (2011) -
THE IMPACT OF PSYCHOTROPE MEDICATION ON ORAL HEALTH
by: Ilinca Untu, et al.
Published: (2020) -
A three-country comparison of psychotropic medication prevalence in youth
by: Gardner James F, et al.
Published: (2008)